Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

Sydney scientists have revealed why receiving a booster vaccine in the same arm as your first dose can generate a more ...

HealthDay News — On Tuesday, the US Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the FDA means a product can stay on the market even after a health emergency ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example of cutting off one’s nose to spite one’s face. | Opinion ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...